Summary of Purpose
The aim of this study is to assess the real world comparative effectiveness of Rivaroxaban prescribed in non-valvular atrial fibrillation (NVAF) routine care patients in Germany.Read More →
The following dates are available for this trial. Trial information last updated on 22 December 2017.
|15 Oct 2016||12 Oct 2016||31 Dec 2016||31 Dec 2016||1 Dec 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|